Literature DB >> 17851744

Silencing of African horse sickness virus VP7 protein expression in cultured cells by RNA interference.

Liesel Stassen1, Henk Huismans, Jacques Theron.   

Abstract

RNA interference (RNAi) is the process by which double-stranded RNA directs sequence-specific degradation of homologous mRNA. Short interfering RNAs (siRNAs) are the mediators of RNAi and represent powerful tools to silence gene expression in mammalian cells including genes of viral origin. In this study, we applied siRNAs targeting the VP7 gene of African horse sickness virus (AHSV) that encodes a structural protein required for stable capsid assembly. Using a VP7 expression reporter plasmid and an in vitro model of infection, we show that synthetic siRNA molecules corresponding to the AHSV VP7 gene silenced effectively VP7 protein and mRNA expression, and decreased production of infectious virus particles as evidenced by a reduction in the progeny virion titres when compared to control cells. This work establishes RNAi as a genetic tool for the study of AHSV and offers new possibilities for the analysis of viral genes important for AHSV physiology.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17851744     DOI: 10.1007/s11262-007-0162-4

Source DB:  PubMed          Journal:  Virus Genes        ISSN: 0920-8569            Impact factor:   2.332


  39 in total

1.  Enhanced gene silencing by the application of multiple specific small interfering RNAs.

Authors:  Jingmin Ji; Marion Wernli; Thomas Klimkait; Peter Erb
Journal:  FEBS Lett       Date:  2003-09-25       Impact factor: 4.124

2.  Protein synthesis in bluetongue virus-infected cells.

Authors:  H Huismans
Journal:  Virology       Date:  1979-01-30       Impact factor: 3.616

Review 3.  Taxonomy of African horse sickness viruses.

Authors:  C H Calisher; P P Mertens
Journal:  Arch Virol Suppl       Date:  1998

4.  Potent and specific genetic interference by double-stranded RNA in Caenorhabditis elegans.

Authors:  A Fire; S Xu; M K Montgomery; S A Kostas; S E Driver; C C Mello
Journal:  Nature       Date:  1998-02-19       Impact factor: 49.962

5.  High doses of siRNAs induce eri-1 and adar-1 gene expression and reduce the efficiency of RNA interference in the mouse.

Authors:  Jie Hong; Zhikang Qian; Shuiyuan Shen; Taishan Min; Chang Tan; JianFeng Xu; Yingchun Zhao; Weida Huang
Journal:  Biochem J       Date:  2005-09-15       Impact factor: 3.857

6.  Plaque formation by African horsesickness virus and characterization of its RNA.

Authors:  R A Oellermann
Journal:  Onderstepoort J Vet Res       Date:  1970-06       Impact factor: 1.792

7.  Intracellular production of African horsesickness virus core-like particles by expression of the two major core proteins, VP3 and VP7, in insect cells.

Authors:  S Maree; S Durbach; H Huismans
Journal:  J Gen Virol       Date:  1998-02       Impact factor: 3.891

8.  Positional effects of short interfering RNAs targeting the human coagulation trigger Tissue Factor.

Authors:  Torgeir Holen; Mohammed Amarzguioui; Merete T Wiiger; Eshrat Babaie; Hans Prydz
Journal:  Nucleic Acids Res       Date:  2002-04-15       Impact factor: 16.971

9.  Inhibition of porcine reproductive and respiratory syndrome virus replication by short hairpin RNA in MARC-145 cells.

Authors:  Juan Huang; Ping Jiang; Yufeng Li; Jiarong Xu; Wenming Jiang; Xianwei Wang
Journal:  Vet Microbiol       Date:  2006-04-11       Impact factor: 3.293

Review 10.  Silencing viruses by RNA interference.

Authors:  Florence Colbère-Garapin; Bruno Blondel; Aure Saulnier; Isabelle Pelletier; Karine Labadie
Journal:  Microbes Infect       Date:  2005-03-13       Impact factor: 2.700

View more
  2 in total

1.  Genetic modification of Bluetongue virus by uptake of "synthetic" genome segments.

Authors:  René G P van Gennip; Daniel Veldman; Sandra G P van de Water; Piet A van Rijn
Journal:  Virol J       Date:  2010-10-07       Impact factor: 4.099

2.  The effect of siRNA treatment on experimental equine herpesvirus type 1 (EHV-1) infection in horses.

Authors:  Margaret M Brosnahan; Armando Damiani; Gerlinde van de Walle; Hollis Erb; Gillian A Perkins; Nikolaus Osterrieder
Journal:  Virus Res       Date:  2009-11-05       Impact factor: 3.303

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.